Dr Luis Gosalbez
Luis is the Director of Business Development at OptiBiotix Health in the UK. Previously, he held different positions in the biotechnology industry and in pharmaceutical consulting in Spain and Germany. His scientific career was developed between Universidad Complutense de Madrid, Centro de Biología Molecular Severo Ochoa-CSIC (both in Spain) and the Korea Advanced Institute of Science and Technology (KAIST, South Korea). His research was always focused on microbiology, the human microbiome and on the development of antimicrobials and antivirals. He received his BSc and MSc in Biotechnology from Universidad Complutense de Madrid, his PhD in Life Sciences from the Catholic University of San Antonio (Spain) and a Master’s in Bioscience Enterprise from the University of Cambridge in the UK.
Dr Soren Krogsgaard Thomsen
Dr Soren Krogsgaard Thomsen is co-founder and CEO of the UK-based start-up company BioMe Oxford. Trained in medical genetics at the Universities of Oxford and Cambridge, Soren has a background in both academic and industrial life sciences research. His publication record spans work on the genetics of complex diseases and academic entrepreneurship. Since co-founding BioMe Oxford, he has successfully led the company to raising pre-seed investment, winning a number of international business competitions along the way (incl. Imagine IF and Idea Idol). Soren dreams of enabling a revolution in precision medicine through population-wide studies of our second genome within.
Evelina Vågesjö, PhD MBA
Co-founder of and developed the concept during PhD 2011-2016, is now CEO and heading the drug and business development in Ilya Pharma. Also BSc in Management Accounting and finished an MBA 2018. Raised >4.3 M€ in grant funding to the project, lead the first private share issue in 2017 and designed stock option programs for key employees.
Gregory McKenzie, Ph.D.
Gregory McKenzie, Ph.D., Vice President and Chief Scientific Officer, has over ten years of experience developing microbial-based products and leading discovery and development teams. Greg was formerly Senior Principal Scientist at Seres Therapeutics where he was a key senior member of the teams that brought the live biotherapeutics SER-109, SER-262, and SER-287 from discovery through proof-of-concept in animals to clinical stage programs.
Mats Wallstrom
Mats is an engineer by education with a special interest in what makes the body perform. He has dedicated years of development of the Qualvivo bacterial boxed-system technology.
Mats is motivated to grow a company and to introduce products on the international market. He identified a window of opportunity to develop the power of bacteria and combined partnering expertise in biotechnology with an engineering approach to develop Qualvivo.
Grégory Lambert
Pharmacist and Ph.D. in pharmaceutical technology, Gregory’s carrier is split between Biotech and Pharma where he occupied the positions of Chief Scientific Officer and Chief Executive Officer. Gregory drove the development of a number of drugs, medical devices and food supplement from the laboratory to market. Since 2014, Gregory is the CEO of TargEDys.
Kristofer Cook
Kristofer is a serial entrepreneur who, over the past 15 years, has co-founded six biotechnology companies in the areas of clean technology, food-technology and life science. In addition to holding multiple board positions in several private and public companies, Kristofer is currently CEO of Carbiotix, an award-winning biotechnology company pioneering microbiome healthcare through a portfolio of microbiome modulators covering prebiotic ingredients, medical foods and therapeutics, along-side a range of cost-effective gut health testing services. Kristofer holds a MSc. degree from Lund University, Sweden, and a M.B.A. degree from Solvay Business School, Belgium.
Dominik Burziwoda
Prior to founding MillionFriends Dominik worked as Head of Operations at the German E-Commerce company Springlane. The company scaled from 8 to >100 people within 3 years. He started his career as an Investment Banker with Lincoln International and worked at Innogy on M&A and financing transactions of renewable energy plant across Europe. He graduated with an LL.M. from University of Munster, with a Master in Finance from IE Business School and holds a BSc in Business from Rotterdam School of Management. He is a passionate snowboarder and healthcare tech enthusiast.
Adam Minto
Adam has over 30 years’ experience in makeup, beauty, fragrance and gift - in both branded, licensed and own brand development.
With a wealth of experience in designing, developing and manufacturing for some of the biggest brands in the world, and the most exciting indie brand, Adam has worked with top health and beauty retailers around the globe. He has an in-depth knowledge of the beauty industry and understands the market fully to know what sells in both an online and in-store environment.
Specialising in speed and results – Adam has launched over 8 brands in the last 10 years. Most recently, he is known for the 4-year-old brand ‘Revolution’ - available in over 50 countries around the world - and has made headline beauty news with some of his recent launches including Conceal & Define and the Banana Powder. Introducing the Fast Beauty concept to key retailers, this fully encapsulates Adam’s passion for bringing leading beauty trends to market in a shorter timeline than any other brand. Adam is also known for talking to customers and Revolution fans at events and being tagged under his alias ‘Mr. Makeup’ in the social media world by Revoholics.
Adam loves makeup ....but outside of that loves spending time with his amazing and beautiful family, eating and drinking in amazing locations (particularly with Team Revolution members around the world) , running, wearing only black clothes and thinking about more beauty ideas!
